This research will explore the organization, structure and expression of
human ferritin genes. Cloned cDNA for H and L chains will be used to
characterize the H and L gene families and to identify genes coding for the
H and L subunits of tissue and serum ferritins. Their chromosomal location
will be determined by in situ hybridization to chromosome spreads and by
hybridization to DNA from separated chromosomes. Expressed genes will be
identified from Southern analysis of DNA from rodent/human hybrid cell
lines that express human H or L chains and by use of specific subprobes
from cDNA clones and the 5' end of ferritin mRNAs. Genomic clones
containing H and L genes will be isolated from genomic libraries. The
organization and structure of expressed genes will be determined by use of
restriction mapping and hybridization of the genomic clones to appropriate
sub-probes, R loop and heteroduplex mapping, and finally by sequencing.
Genes exhibiting conditional or tissue-specific differential expression
will be identified and elements involved in possible regulation of their
expression will be analyzed. Exon-intro junctions will be identified as
well as possible regulatory sequences at the 5' end of the genes that may
be involved in initiation or regulation of transcription or processing of
tissue specific ferritins. These studies will eventually lead to an
analysis of factors that might control the regulation of expression of H
and L chains in different tissues and at different developmental stages.
We shall investigate the possibility that defects in iron metabolism such
as hemochromatosis or neonatal iron storage disease are causally related to
abnormalities in ferritin expression. In related collaborative studies we
shall explore the use of ferritin probes to determine whether any will be
useful markers for identifying restriction fragment length polymorphisms
associated with other inherited diseases where an altered gene lies close
to ferritin. In parallel studies, we shall examine the interaction of
ferritin mRNA and proteins and ribosomal RNA sequences in messenger
ribonucleoprotein particles to explore their function in translational
control of ferritin synthesis.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
039318308
UEI
C1F5LNUF7W86
Project Start Date
01-July-1977
Project End Date
31-August-1991
Budget Start Date
01-September-1988
Budget End Date
31-August-1989
Project Funding Information for 1988
Total Funding
$179,280
Direct Costs
$105,459
Indirect Costs
$73,821
Year
Funding IC
FY Total Cost by IC
1988
National Institute of Diabetes and Digestive and Kidney Diseases
$179,280
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DK017775-15
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DK017775-15
Patents
No Patents information available for 5R01DK017775-15
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DK017775-15
Clinical Studies
No Clinical Studies information available for 5R01DK017775-15
News and More
Related News Releases
No news release information available for 5R01DK017775-15
History
No Historical information available for 5R01DK017775-15
Similar Projects
No Similar Projects information available for 5R01DK017775-15